Siponimod (BAF312) penetrates, distributes, and acts in the central nervous system: Preclinical insights.
Marc BigaudBettina RudolphEmmanuelle BriardChristian BeerliAndreas HofmannErwin HermesFlorian MuellershausenAnna SchubartAnne GardinPublished in: Multiple sclerosis journal - experimental, translational and clinical (2021)
Findings demonstrate siponimod's CNS penetration and distribution across species, with high translational potential to human.